Marcia L Stefanick1, Robert L Brunner2, X Leng3, Marian C Limacher4, Chloe E Bird5, David O Garcia6, Patricia E Hogan3, Michael J LaMonte7, Rachel H Mackey8, Karen C Johnson9, Andrea LaCroix10, Jennifer G Robinson11, Rebecca A Seguin12, Hilary A Tindle13, Sylvia Wassertheil-Smoller14. 1. Department of Medicine, Stanford Prevention Research Center and Department of Obstetrics & Gynecology, School of Medicine, Stanford University, California. stefanick@stanford.edu. 2. Department of Family and Community Medicine, University of Nevada School of Medicine, Reno. 3. Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina. 4. Division of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville. 5. RAND Corporation, Santa Monica, California. 6. Department of Health Promotion Sciences, University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson. 7. Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo - SUNY, New York. 8. Department of Epidemiology, School of Public Health, University of Pittsburgh, Pennsylvania. 9. Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis. 10. Department of Family and Preventative Medicine, University of California San Diego, La Jolla, California. 11. Department of Epidemiology, College of Public Health, University of Iowa. 12. Division of Nutritional Sciences, Cornell University, Ithica, New York. 13. Center for Research on Health Care, University of Pittsburgh, Pennsylvania. 14. Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, New York.
Abstract
BACKGROUND: Cardiovascular disease (CVD) is highly prevalent at ages 80 and above. The association of physical functioning (PF), a key to an optimal aging trajectory, with CVD and specific CVD diagnosis in women who survive to age 80 and above has not been described previously and has important public health significance given our aging population. METHODS: Women's Health Initiative participants aged 80 years or older at the time of self-reporting PF (RAND SF-36) were studied in relationship to CVD diagnosis, whether present at study baseline (1993-1998) or diagnosed during follow-up through 2012. Cross-sectional analyses utilized demographic, medical, lifestyle, and psycho-social questionnaire data from baseline or updated at the time of self-reported PF. RESULTS: Among 27,145 older Women's Health Initiative participants, 22.0% (N = 5,959) had been diagnosed with CVD, specifically: 11.3% (N = 3,071) with coronary heart disease; 4.7% (N = 1,279), stroke; 5.2% (N = 1,397), venous thromboembolism; 2.7% (N = 737), peripheral arterial disease; and 2.7% (N = 725), congestive heart failure. PF scores (mean ± SE) were significantly (p < .0001) higher without CVD (60.0 ± 26.9), compared with any CVD (47.9 ± 27.3), and for each specific CVD diagnosis: coronary heart disease (48.8 ± 27.1); stroke (44.8 ± 27.9); venous thromboembolism (48.9 ± 27.4); peripheral arterial disease (41.9 ± 2.2); and congestive heart failure (38.8 ± 26.1). Regardless of CVD diagnosis, higher PF was associated with: younger age at the time of PF assessment; lower body mass index; higher recreational physical activity; better self-reported general health; fewer hip fractures after age 55; no history of arthritis; and no recent use of non-steroidal anti-inflammatory drugs. CONCLUSIONS: Older women with any CVD, and particularly women with congestive heart failure or peripheral arterial disease, reported significantly lower PF compared to women with no CVD. Regardless of CVD diagnosis, higher PF was strongly associated with a more active lifestyle and lower body mass index, suggesting potential intervention targets for more optimal aging.
BACKGROUND:Cardiovascular disease (CVD) is highly prevalent at ages 80 and above. The association of physical functioning (PF), a key to an optimal aging trajectory, with CVD and specific CVD diagnosis in women who survive to age 80 and above has not been described previously and has important public health significance given our aging population. METHODS:Women's Health Initiative participants aged 80 years or older at the time of self-reporting PF (RAND SF-36) were studied in relationship to CVD diagnosis, whether present at study baseline (1993-1998) or diagnosed during follow-up through 2012. Cross-sectional analyses utilized demographic, medical, lifestyle, and psycho-social questionnaire data from baseline or updated at the time of self-reported PF. RESULTS: Among 27,145 older Women's Health Initiative participants, 22.0% (N = 5,959) had been diagnosed with CVD, specifically: 11.3% (N = 3,071) with coronary heart disease; 4.7% (N = 1,279), stroke; 5.2% (N = 1,397), venous thromboembolism; 2.7% (N = 737), peripheral arterial disease; and 2.7% (N = 725), congestive heart failure. PF scores (mean ± SE) were significantly (p < .0001) higher without CVD (60.0 ± 26.9), compared with any CVD (47.9 ± 27.3), and for each specific CVD diagnosis: coronary heart disease (48.8 ± 27.1); stroke (44.8 ± 27.9); venous thromboembolism (48.9 ± 27.4); peripheral arterial disease (41.9 ± 2.2); and congestive heart failure (38.8 ± 26.1). Regardless of CVD diagnosis, higher PF was associated with: younger age at the time of PF assessment; lower body mass index; higher recreational physical activity; better self-reported general health; fewer hip fractures after age 55; no history of arthritis; and no recent use of non-steroidal anti-inflammatory drugs. CONCLUSIONS: Older women with any CVD, and particularly women with congestive heart failure or peripheral arterial disease, reported significantly lower PF compared to women with no CVD. Regardless of CVD diagnosis, higher PF was strongly associated with a more active lifestyle and lower body mass index, suggesting potential intervention targets for more optimal aging.
Authors: J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty Journal: Ann Epidemiol Date: 2003-10 Impact factor: 3.797
Authors: T A Hoeven; M J G Leening; P J Bindels; M Castaño-Betancourt; J B van Meurs; O H Franco; M Kavousi; A Hofman; M A Ikram; J C M Witteman; S M Bierma-Zeinstra Journal: Ann Rheum Dis Date: 2014-01-02 Impact factor: 19.103
Authors: Nancy K Latham; Bette Ann Harris; Jonathan F Bean; Timothy Heeren; Christine Goodyear; Stacey Zawacki; Diane M Heislein; Jabed Mustafa; Poonam Pardasaney; Marie Giorgetti; Nicole Holt; Lori Goehring; Alan M Jette Journal: JAMA Date: 2014-02-19 Impact factor: 56.272
Authors: L F Berkman; T E Seeman; M Albert; D Blazer; R Kahn; R Mohs; C Finch; E Schneider; C Cotman; G McClearn Journal: J Clin Epidemiol Date: 1993-10 Impact factor: 6.437
Authors: Kristen M Beavers; Daniel P Beavers; Beverly A Nesbit; Walter T Ambrosius; Anthony P Marsh; Barbara J Nicklas; W Jack Rejeski Journal: Obesity (Silver Spring) Date: 2013-09-20 Impact factor: 5.002
Authors: K A Hagan; L B Harrington; J Kim; O Zeleznik; E B Rimm; F Grodstein; C Kabrhel Journal: J Thromb Haemost Date: 2018-06-08 Impact factor: 5.824
Authors: Kristin Pullyblank; David Strogatz; Sara C Folta; Lynn Paul; Miriam E Nelson; Meredith Graham; Grace A Marshall; Galen Eldridge; Stephen A Parry; Sean Mebust; Rebecca A Seguin Journal: J Rural Health Date: 2019-03-13 Impact factor: 4.333
Authors: Connor R Miller; Jean Wactawski-Wende; JoAnn E Manson; Bernhard Haring; Kathleen M Hovey; Deepika Laddu; Aladdin H Shadyab; Robert A Wild; Jennifer W Bea; Lesley F Tinker; Lisa W Martin; Patricia K Nguyen; Lorena Garcia; Christopher A Andrews; Charles B Eaton; Marcia L Stefanick; Michael J LaMonte Journal: Hypertension Date: 2020-09-28 Impact factor: 10.190
Authors: Aozhou Wu; Josef Coresh; Elizabeth Selvin; Hirofumi Tanaka; Gerardo Heiss; Alan T Hirsch; Bernard G Jaar; Kunihiro Matsushita Journal: J Am Heart Assoc Date: 2017-01-20 Impact factor: 5.501
Authors: Pamela L Lutsey; B Gwen Windham; Jeffrey R Misialek; Mary Cushman; Anna Kucharska-Newton; Saonli Basu; Aaron R Folsom Journal: J Am Heart Assoc Date: 2020-06-01 Impact factor: 5.501
Authors: Brittney S Lange-Maia; Kelly Karavolos; Elizabeth F Avery; Elsa S Strotmeyer; Carrie A Karvonen-Gutierrez; Bradley M Appelhans; Imke Janssen; Sheila A Dugan; Howard M Kravitz Journal: Womens Midlife Health Date: 2020-07-28